Business Development | Partners & Collaborators

MediciNova is collaborating with Mitsubishi Tanabe Pharma Corporation in the global development of MN-305 and MN-246.

Mitsubishi Tanabe Pharma Corporation

www.m-pharma.co.jp

MediciNova is collaborating with Kissei Pharmaceutical Co., Ltd. in the global development of MN-221.

Kissei Pharmaceutical Co., Ltd.

www.kissei.co.jp

MediciNova is collaborating with Kyorin Pharmaceutical Co., Ltd. in the global development of MN-001 and MN-166.

Kyorin Pharmaceutical Co., Ltd.

www.kyorin-pharm.co.jp

MediciNova is collaborating with Angiogene Pharmaceuticals Ltd. in the development of MN-029 for cancer treatment.

Angiogene Pharmaceuticals Ltd.

www.angiogene.co.uk
MediciNova is collaborating with Meiji Seika Kaisha, Ltd. in the global development of MN-447 and MN-462.

Meiji Seika Kaisha Ltd.

www.meiji.co.jp